Advertisement.

ENZN Projected Dividend Yield

Enzon Pharmaceuticals Inc ( OTCBB : ENZN )

Enzon Pharmaceuticals is engaged in licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum. Vicineum, a drug being developed by Sesen, Inc., is approved for the treatment of non-muscle invasive bladder cancer.

22 YEAR PERFORMANCE RESULTS

ENZN Dividend History Detail
ENZN Dividend News
ENZN Competitors News

# of Shares: 0

Closing Price: 0.11

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2012	2.00	0%	0	$ 0.00	0.00%
2013	2.05	2%	0	$ 0.00	0.00%
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.85	0%	0	$ 0.00	0.00%
2016	0.15	0%	0	$ 0.00	0.00%
2017	0.15	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.12	0%	0	$ 0.00	105.49%
2025	0.00	0%	0	$ 0.00	105.49%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 105.49%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2019	Aug 22, 2019	Sep 30, 2019	Oct 01, 2019	Oct 15, 2019	0.1200
2019	Jan 30, 2019	Feb 20, 2019	Feb 21, 2019	Mar 21, 2019	0.0600
2019 Total:					0.1800